“LL-37”的搜索结果，显示 261-270 项，共有 6951 项

1. 肾病和高血压- 临床试验- 妙佑医疗国际

   Go to page 22 · Go to page 33 · Go to page 44. 以下为当前的临床试验。 37 研究肾病和高血压（仅限开放性研究）. 按位置、状态和其他条件筛选该研究列表。 REstrictive ...

2. 血液科- 临床试验- 妙佑医疗国际

   ... 2). In Part 1, different level of step-up doses are tested followed by the target dose of ABBV-383. In Part 2, the step-up dose identified in Part 1 will be ...

3. 血液科- 临床试验- 妙佑医疗国际

   ... II dose (RP2D of APG2575 in combination with Pomalidomide/dexamethasone (Pd) in patients with relapsed/refractory (R/R) multiple myeloma (MM), or ...

4. 神经科- 临床试验- 妙佑医疗国际

   ... 2 participants will also undergo MRI scanning, comprehensive cognitive ... (2) Cohort 2 focuses on primary or secondary myelofibrosis (MF) displaying ...

5. 乳腺专科门诊- 临床试验- 妙佑医疗国际

   This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor positive/ ...

6. 神经科- 临床试验- 妙佑医疗国际

   ... 2 participants will also undergo MRI scanning, comprehensive cognitive ... (2) Cohort 2 focuses on primary or secondary myelofibrosis (MF) displaying ...

7. 耳鼻喉科(ENT) /头颈外科- 临床试验- 妙佑医疗国际

   This phase II trial compares the impact of subcutaneous (SC) nivolumab given in an in-home setting to an in-clinic setting on cancer care and quality of life.

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Phase 2 Study with TTI-622 and TTI-621 in Relapsed Diffuse Large B-Cell Lymphoma (DLBCL). Rochester, Minn. The purpose of ths study is to find out more about ...

9. 血液科- 临床试验- 妙佑医疗国际

   ... 2). In Part 1, different level of step-up doses are tested followed by the target dose of ABBV-383. In Part 2, the step-up dose identified in Part 1 will be ...

10. 肺科- 临床试验- 妙佑医疗国际

    Go to page 22 · Go to page 33 · NextNext Page. 以下为当前的临床试验。 27 研究肺科（仅限开放性研究）. 按位置、状态和其他条件筛选该研究列表。 A Study To Evaluate ...